[SLN] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -358.15%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Annual Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 0 15 117 163 694 2,366 1,723 -
PBT -9,429 -11,980 -9,002 -26,284 -5,737 -8,795 -7,508 3.86%
Tax -2,784 -892 -70 -30 -49 137 -37 105.40%
NP -6,645 -11,088 -9,002 -26,284 -5,737 -8,795 -7,471 -1.93%
Tax Rate - - - - - - - -
Total Cost 6,645 11,103 9,119 26,447 6,431 11,161 9,194 -5.26%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 0.00 -73,920.00 -7,694.02 -16,125.15 -826.66 -371.72 -433.60 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -0.31 -0.66 -0.61 -4.11 -1.84 -4.74 -8.32 -42.19%
EPS Diluted -0.31 -0.66 -0.61 -4.11 -1.84 -4.74 -8.32 -42.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.